26 related articles for article (PubMed ID: 7284057)
1. [Prognostic histopathological features of malignant melanoma. New statistical approaches (author's transl)].
Le Doussal V; Brunet M; Guérin P; Hacene K; Lasry S; Marcotorchino F; Michaud P; Hebert H; Gest J
Nouv Presse Med; 1981 Aug 29-Sep 5; 10(31):2561-3. PubMed ID: 7279632
[TBL] [Abstract][Full Text] [Related]
2. Independent prognostic importance of vascular invasion in nodular melanomas.
Straume O; Akslen LA
Cancer; 1996 Sep; 78(6):1211-9. PubMed ID: 8826942
[TBL] [Abstract][Full Text] [Related]
3. Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging.
Marghoob AA; Koenig K; Bittencourt FV; Kopf AW; Bart RS
Cancer; 2000 Feb; 88(3):589-95. PubMed ID: 10649252
[TBL] [Abstract][Full Text] [Related]
4. Identification of higher risk thin melanomas should be based on Breslow depth not Clark level IV.
Owen SA; Sanders LL; Edwards LJ; Seigler HF; Tyler DS; Grichnik JM
Cancer; 2001 Mar; 91(5):983-91. PubMed ID: 11251950
[TBL] [Abstract][Full Text] [Related]
5. Histopathologic study of recurrent Clark level II melanomas.
Glass LF; Guffey JM; Schroer KR; Reintgen D
Semin Surg Oncol; 1993; 9(3):202-7. PubMed ID: 8516604
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic histopathological features of cutaneous malignant melanomas. New statistical approach (author's transl)].
Le Doussal V; Brunet M; Guérin P; Hacène K; Lasry S; Marcotorchino F; Michaud P; Hébert H
Ann Pathol; 1981; 1(2):130-9. PubMed ID: 7284057
[TBL] [Abstract][Full Text] [Related]
7. Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma.
Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R
Melanoma Res; 2007 Dec; 17(6):393-9. PubMed ID: 17992123
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous melanoma: estimating survival and recurrence risk based on histopathologic features.
Elder DE; Gimotty PA; Guerry D
Dermatol Ther; 2005; 18(5):369-85. PubMed ID: 16297012
[TBL] [Abstract][Full Text] [Related]
9. Unusual histological variants of cutaneous malignant melanoma with some clinical and possible prognostic correlations.
Rongioletti F; Smoller BR
J Cutan Pathol; 2005 Oct; 32(9):589-603. PubMed ID: 16176296
[TBL] [Abstract][Full Text] [Related]
10. [Experiences with the new American Joint Committee on Cancer (AJCC) classification of cutaneous melanoma].
Eigentler TK; Radny P; Kamin A; Weide B; Caroli UM; Garbe C
J Dtsch Dermatol Ges; 2005 Aug; 3(8):592-8. PubMed ID: 16033477
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic factors in thin cutaneous malignant melanoma].
Massi D; Franchi A; Santucci M
Pathologica; 2002 Dec; 94(6):282-9. PubMed ID: 12540991
[TBL] [Abstract][Full Text] [Related]
12. [Histopathological prognostic factors of malignant melanoma].
Plótár V; Orosz Z; Tóth E; Szentirmay Z
Magy Onkol; 2007; 51(1):39-46. PubMed ID: 17417674
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
